Alopecia areata following pembrolizumab: A case report and literature review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Alopecia areata following pembrolizumab: A case report and literature review

Published:2022-04-13 Issue:4 Volume:5 Page:153-154
ISSN:2574-4593
Container-title:Journal of Cutaneous Immunology and Allergy
language:en
Short-container-title:J Cutaneous Imm & Allergy

Author:

Hara Reiko¹,Sawada Yu¹^ORCID

Affiliation:

1. Department of Dermatology University of Occupational and Environmental Health Kitakyushu Japan

Publisher

Wiley

Subject

Dermatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cia2.12236

Reference8 articles.

1. STING Signaling and Skin Cancers

2. Nivolumab plus Ipilimumab in Advanced Melanoma

3. Cutaneous innate immune tolerance is mediated by epigenetic control of MAP2K3 by HDAC8/9

4. Alopecia areata: Current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines

5. Collapse and Restoration of MHC Class-I-Dependent Immune Privilege

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medication-induced hair loss: An update;Journal of the American Academy of Dermatology;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3